Aug. 19, 2024 — The avian influenza virus needs to mutate to cross the species barrier and to infect and replicate within mammalian cells. Scientists have now deciphered the structure of the ...
OVX836 is a first-in-class influenza A vaccine candidate that targets the nucleoprotein (NP ... to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell ...